Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 21 citing articles:

Pausing methotrexate improves immunogenicity of COVID-19 vaccination in elderly patients with rheumatic diseases
Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Fredrik N. Albach, et al.
Annals of the Rheumatic Diseases (2022) Vol. 81, Iss. 6, pp. 881-888
Open Access | Times Cited: 47
Rheumatologische Versorgung in Deutschland
Joseph M. Braun, K. Albrecht, Johanna Callhoff, et al.
Zeitschrift für Rheumatologie (2024) Vol. 83, Iss. S2, pp. 249-284
Closed Access | Times Cited: 9
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, et al.
RMD Open (2022) Vol. 8, Iss. 2, pp. e002650-e002650
Open Access | Times Cited: 20
Humoral immunogenicity of COVID-19 vaccines in patients with inflammatory rheumatic diseases under treatment with Rituximab: a case–control study (COVID-19VacRTX)
Falk Schumacher, Nikola Mrdenovic, Dennis Scheicht, et al.
Lara D. Veeken (2022) Vol. 61, Iss. 10, pp. 3912-3918
Open Access | Times Cited: 17
Chronic pain, fibromyalgia, and long COVID
J. Braun
Exploration of Musculoskeletal Diseases (2025)
Closed Access
Chronische Schmerzsyndrome bei muskuloskelettalen Erkrankungen – wie verschieden sind Fibromyalgie und Long COVID? – Teil 1
J. Braun
Zeitschrift für Rheumatologie (2025)
Closed Access
Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden
Julia U. Holle, Torsten Kubacki, Philippe Ariès, et al.
Zeitschrift für Rheumatologie (2025) Vol. 84, Iss. S1, pp. 1-49
Closed Access
Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis – a retrospective analysis from the RHADAR database
Linus Maximilian Risser, Torsten Witte, Matthias Englbrecht, et al.
Rheumatology International (2025) Vol. 45, Iss. 5
Closed Access
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) survey
Leonardo Santos Hoff, R Naveen, Samuel Katsuyuki Shinjo, et al.
Rheumatology International (2022) Vol. 43, Iss. 1, pp. 47-58
Open Access | Times Cited: 16
Self-collection of capillary blood and saliva to determine COVID-19 vaccine immunogenicity in patients with immune-mediated inflammatory diseases and health professionals
Caroline Schmetzer, Ekaterina Vogt, Laura Stellar, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 9
COVID-19 Vaccination Coverage in Patients with Rheumatic Diseases in a German Outpatient Clinic: An Observational Study
Marco Krasselt, Christoph Baerwald, Olga Seifert
Vaccines (2022) Vol. 10, Iss. 2, pp. 253-253
Open Access | Times Cited: 8
Severe COVID-19 in patients with immune-mediated rheumatic diseases: A stratified analysis from the SORCOM multicentre registry
Alina Boteanu, Leticia León, Silvia Pérez, et al.
Modern Rheumatology (2022) Vol. 34, Iss. 1, pp. 97-105
Open Access | Times Cited: 5
COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient survey
Anna Kernder, Tim Filla, Kirsten de Groot, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 2
Dos and Don’ts in der rheumatologischen Primärversorgung
René Thonhofer
rheuma plus (2024) Vol. 23, Iss. 3, pp. 184-190
Closed Access
Management of ANCA-associated vasculitides
Christian Löffler, Bernhard Hellmich
Deleted Journal (2024) Vol. 65, Iss. 2, pp. 93-106
Closed Access
Clinical management in the COVID-19 pandemic: Rheumatic disease
Abdulvahap Kahveci, Şebnem Ataman
Elsevier eBooks (2024), pp. 111-121
Closed Access
The German Society for Rheumatology and Clinical Immunology (DGRh) and the COVID-19 pandemic
Anna Voormann, Christof Specker
Zeitschrift für Rheumatologie (2024) Vol. 83, Iss. 7, pp. 520-527
Closed Access
COVID-19 und rheumatische Erkrankungen – bisherige Erkenntnisse der Pandemie
Rebecca Hasseli, Ulf Müller Ladner
DMW - Deutsche Medizinische Wochenschrift (2021) Vol. 146, Iss. 23, pp. 1564-1568
Closed Access | Times Cited: 1
Abstracts zum 128. Kongress der Deutschen Gesellschaft für Innere Medizin e.V.

Der Internist (2022) Vol. 63, Iss. S3, pp. 299-364
Open Access
Sind SARS-CoV-2-reaktive T‑Zellen bei Patienten unter Anti-CD20-Therapie mit einer beeinträchtigten humoralen Antwort nachweisbar und potenziell protektiv?
J. Braun, Timm H. Westhoff, Xenofon Baraliakos, et al.
Zeitschrift für Rheumatologie (2021) Vol. 80, Iss. 9, pp. 879-883
Open Access
COVID-19 in der rheumatologischen Routineversorgung
S. G. Werner, Helmut Länger, R Châtelain
rheuma plus (2021) Vol. 20, Iss. 6, pp. 267-271
Open Access
Page 1

Scroll to top